Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Pfizer (PFE) topped second quarter expectations, but looming Trump-era pharmaceutical tariffs remain a concern. Pfizer CEO ...

The biotech industry needs to be supported by the government, by Congress,” Pfizer’s Albert Bourla told investors Tuesday in ...

Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other ...

Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc, was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine.

Pharma giant Pfizer has appointed a new chief operating officer in the form of Albert Bourla, who has been the group president of Pfizer’s innovative health business since the beginning of 2016. Prior ...

Pfizer is pivoting from Covid to cancer, and putting most of its resources into oncology, its CEO has said. Albert Bourla told an event hosted by IDA Ireland in Dublin that all the money his ...